logo
episode-header-image
Mar 2021
9m 44s

Ariana Znaor on breast and cervical canc...

The Lancet Group
About this episode
Ariana Znaor, International Agency for Research on Cancer, discusses her Article on breast and cervical cancers stage distributions in ten newly independent states of the former Soviet Union. Read the full article: https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(20)30674-4/fulltext Tell us what you thought about this episode Continue this co ... Show More
Up next
Yesterday
Andre Pfob and Peter Dubsky on The Lucerne Toolbox 3
<p>Dr Andre Pfob (Department of Obstetrics &amp; Gynecology, Heidelberg University Hospital) and Prof Peter Dubsky (Faculty of Health Sciences and Medicine, University of Lucerne) discuss their Review entitled The Lucerne Toolbox 3: digital health and artificial intelligence to o ... Show More
25m 41s
Nov 2
Gary Rodin on The human crisis in cancer: a Lancet Oncology Commission
<p>Dr Gary Rodin discusses The human crisis in cancer: a <em>Lancet Oncology</em> Commission which identifies a growing imbalance between technological innovation and the human dimensions of cancer care.</p><p>Click here to read the full Commission: <a href='https://www.thelancet ... Show More
10m 46s
Oct 27
Matthias Preusser on the phase 2 TUXEDO-3 trial
<p>Deputy Editor Ali Landman speaks with Matthias Preusser (Medical University of Vienna, Vienna, Austria) about two reports from the phase 2 TUXEDO-3 trial investigating patritumab deruxtecan (HER3-Dxd) in patients with active brain metastases of breast cancer or non-small-cell ... Show More
17m 10s
Recommended Episodes
Jul 2024
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Gynecologic Oncology
Dr Dana M Chase from the David Geffen School of Medicine at UCLA in Los Angeles, California, discusses select 2023 data sets on the management of ovarian, endometrial and cervical cancers. 
59m 17s
Jul 2024
Ep. 178 ASCO 2024: Game-Changing GU Oncology Updates in Bladder and Kidney Cancers with Dr. Sumanta Pal and Dr. Petros Grivas
Stay up-to-date on the latest advancements and treatment strategies in the field of genitourinary oncology. In this episode of BackTable Urology, guest host Dr. Bogdana Schmidt, a urologic oncologist from the University of Utah, discusses takeaways from ASCO 2024 with Dr. Petros ... Show More
56m 23s
Sep 29
Breast Cancer — 5-Minute Journal Club Issue 3 with Dr Kevin Kalinsky: Defining the Role of TROP2-Directed Antibody-Drug Conjugates
Dr Kevin Kalinsky from the Winship Cancer Institute of Emory University in Atlanta, Georgia, discusses recent developments with TROP2-directed antibody-drug conjugates in the management of breast cancer. CME information and select publications here. 
21m 51s
Dec 2023
Cristina A. Pop, "The Cancer Within: Reproduction, Cultural Transformation, and Health Care in Romania" (Rutgers UP, 2022)
In The Cancer Within: Reproduction, Cultural Transformation, and Health Care in Romania (Rutgers UP, 2022), Cristina Pop examines cervical cancer in Romania as a point of entry into an anthropological reflection on contemporary health care, especially in the post-communist contex ... Show More
1h 22m
Jun 2024
Early Detection, Mammograms & Breast Cancer Care with Dr. Rachel Brem
320. Early Detection, Mammograms & Breast Cancer Care with Dr. Rachel Brem Amanda shares an update on her recovery from breast cancer. Then, renowned breast cancer expert, Dr. Rachel Brem, joins the conversation to discuss the critical importance of early detection, breast densi ... Show More
49m 7s
Jun 2022
Podcast 293: HER2-“low” breast cancer and its reponse to an antibody-drug conjugate
<p>Patients with metastatic breast cancer whose tumors express low levels of HER2 are generally classified and treated as having HER2-negative disease.</p> <p>However, Dr. Shanu Modi of the Memorial Sloan Kettering Cancer Center and a group of international collaborators explored ... Show More
11m 24s
Oct 2023
Unlocking Breast Cancer Resilience: The Impact of Shame, Love & Holistic Healing - Dr. Toni Galardi : 1095
<p>Every 13 minutes, a woman dies of breast cancer. And this unnecessary epidemic affects men, too. Today, you’ll hear a fascinating interview with a woman on a mission to empower people to do more than just survive breast cancer, but become radiantly healthy; Dr. Toni Galardi.&n ... Show More
55m 23s
Oct 2024
Localized Breast Cancer 2024 UPDATE
<p>This week’s episode  is part 2 of 2024 updates focusing on treatment options for localized breast cancer. We will discuss important details on radiation, as well as therapies based on ER/PR/her2 receptor status. We are honored to have Dr. Eleonora Teplinsky, a board-certified ... Show More
28m 49s
Dec 2024
139. Back to Basics - Early HER2 Breast Cancer
<p>Human epidermal growth factor receptor 2 (HER2) is overexpressed in multiple cancers, including breast, gastric, colorectal, and epithelial ovarian cancers. However, this receptor's complexity doesn't stop there. It has multiple subdomains and various responses to drugs, and t ... Show More
24m 31s
Oct 21
Interview: Could we detect breast cancer with a fingerprint? with Dr. Dhivya Srinivasa
Breast cancer is the most common cancer among women globally. And yet, many people pass up opportunities to get screened for the disease, often because of the invasive and sometimes painful process of mammograms. Chemist and professor Simona Francese presents a potentially ground ... Show More
31m 57s